GH Research Plc

Shares of $GHRS have slid the past 2 days as it still has one remaining issue on its clinical hold of its Investigational New Drug Application for GH001. Despite the recent slide its daily uptrend remains intact.

Share this article:

About the Author:

GH Research Plc

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup